HBK Investments’s CytomX Therapeutics CTMX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q4
Sell
-49,400
Closed -$914K 1089
2018
Q3
$914K Buy
+49,400
New +$914K 0.01% 631